nodes	percent_of_prediction	percent_of_DWPC	metapath
Arformoterol—CYP2A6—Rifampicin—leprosy	0.28	0.316	CbGbCtD
Arformoterol—CYP2C19—Thalidomide—leprosy	0.12	0.135	CbGbCtD
Arformoterol—CYP2C19—Rifampicin—leprosy	0.116	0.131	CbGbCtD
Arformoterol—CYP2C9—Thalidomide—leprosy	0.0994	0.112	CbGbCtD
Arformoterol—CYP2C9—Rifampicin—leprosy	0.0963	0.109	CbGbCtD
Arformoterol—CYP2C19—Dapsone—leprosy	0.0956	0.108	CbGbCtD
Arformoterol—CYP2C9—Dapsone—leprosy	0.0795	0.0897	CbGbCtD
Arformoterol—Circumoral paresthesia—Thalidomide—leprosy	0.00469	0.0412	CcSEcCtD
Arformoterol—Pyuria—Thalidomide—leprosy	0.00438	0.0384	CcSEcCtD
Arformoterol—Hernia—Thalidomide—leprosy	0.00326	0.0286	CcSEcCtD
Arformoterol—Paraesthesia oral—Thalidomide—leprosy	0.00326	0.0286	CcSEcCtD
Arformoterol—Neck stiffness—Thalidomide—leprosy	0.00321	0.0282	CcSEcCtD
Arformoterol—Nuchal rigidity—Thalidomide—leprosy	0.00295	0.0259	CcSEcCtD
Arformoterol—Oral candidiasis—Thalidomide—leprosy	0.00241	0.0211	CcSEcCtD
Arformoterol—Lung disorder—Thalidomide—leprosy	0.00216	0.019	CcSEcCtD
Arformoterol—Hyperlipidaemia—Thalidomide—leprosy	0.00212	0.0186	CcSEcCtD
Arformoterol—Nasopharyngitis—Dapsone—leprosy	0.00194	0.017	CcSEcCtD
Arformoterol—Influenza—Dapsone—leprosy	0.00187	0.0165	CcSEcCtD
Arformoterol—Musculoskeletal stiffness—Thalidomide—leprosy	0.0017	0.015	CcSEcCtD
Arformoterol—Skin discolouration—Thalidomide—leprosy	0.00169	0.0149	CcSEcCtD
Arformoterol—Bone disorder—Thalidomide—leprosy	0.00169	0.0149	CcSEcCtD
Arformoterol—Viral infection—Thalidomide—leprosy	0.00169	0.0149	CcSEcCtD
Arformoterol—Herpes simplex—Thalidomide—leprosy	0.00166	0.0146	CcSEcCtD
Arformoterol—Leukocytosis—Thalidomide—leprosy	0.00163	0.0143	CcSEcCtD
Arformoterol—Atrioventricular block—Thalidomide—leprosy	0.00158	0.0138	CcSEcCtD
Arformoterol—Sinusitis—Dapsone—leprosy	0.00157	0.0138	CcSEcCtD
Arformoterol—Hyperkalaemia—Thalidomide—leprosy	0.0015	0.0132	CcSEcCtD
Arformoterol—Pharyngitis—Dapsone—leprosy	0.00149	0.0131	CcSEcCtD
Arformoterol—Candida infection—Thalidomide—leprosy	0.00146	0.0128	CcSEcCtD
Arformoterol—Cramps of lower extremities—Thalidomide—leprosy	0.0014	0.0123	CcSEcCtD
Arformoterol—Gastroenteritis—Thalidomide—leprosy	0.00125	0.011	CcSEcCtD
Arformoterol—Cardiac failure congestive—Thalidomide—leprosy	0.00122	0.0107	CcSEcCtD
Arformoterol—Injury—Thalidomide—leprosy	0.00121	0.0106	CcSEcCtD
Arformoterol—Atrial fibrillation—Thalidomide—leprosy	0.00117	0.0103	CcSEcCtD
Arformoterol—Arthritis—Thalidomide—leprosy	0.00114	0.01	CcSEcCtD
Arformoterol—Cough—Dapsone—leprosy	0.00114	0.01	CcSEcCtD
Arformoterol—Hypoglycaemia—Thalidomide—leprosy	0.00114	0.00999	CcSEcCtD
Arformoterol—Tachycardia—Dapsone—leprosy	0.00104	0.00913	CcSEcCtD
Arformoterol—Dehydration—Thalidomide—leprosy	0.00103	0.00907	CcSEcCtD
Arformoterol—Dry skin—Thalidomide—leprosy	0.00102	0.00894	CcSEcCtD
Arformoterol—Hypokalaemia—Thalidomide—leprosy	0.00101	0.00887	CcSEcCtD
Arformoterol—Cramp muscle—Thalidomide—leprosy	0.000999	0.00878	CcSEcCtD
Arformoterol—Insomnia—Dapsone—leprosy	0.000964	0.00847	CcSEcCtD
Arformoterol—Influenza—Thalidomide—leprosy	0.000959	0.00843	CcSEcCtD
Arformoterol—Bronchospasm—Thalidomide—leprosy	0.000944	0.00829	CcSEcCtD
Arformoterol—Angina pectoris—Thalidomide—leprosy	0.000934	0.00821	CcSEcCtD
Arformoterol—Bronchitis—Thalidomide—leprosy	0.000923	0.0081	CcSEcCtD
Arformoterol—Upper respiratory tract infection—Thalidomide—leprosy	0.000892	0.00783	CcSEcCtD
Arformoterol—Gastrointestinal pain—Dapsone—leprosy	0.000871	0.00765	CcSEcCtD
Arformoterol—Hyperglycaemia—Thalidomide—leprosy	0.000865	0.0076	CcSEcCtD
Arformoterol—Acute coronary syndrome—Thalidomide—leprosy	0.000843	0.00741	CcSEcCtD
Arformoterol—Abdominal pain—Dapsone—leprosy	0.000842	0.0074	CcSEcCtD
Arformoterol—Body temperature increased—Dapsone—leprosy	0.000842	0.0074	CcSEcCtD
Arformoterol—Myocardial infarction—Thalidomide—leprosy	0.000838	0.00736	CcSEcCtD
Arformoterol—Conjunctivitis—Thalidomide—leprosy	0.000831	0.0073	CcSEcCtD
Arformoterol—Haematuria—Thalidomide—leprosy	0.000816	0.00716	CcSEcCtD
Arformoterol—Sinusitis—Thalidomide—leprosy	0.000802	0.00705	CcSEcCtD
Arformoterol—Rhinitis—Thalidomide—leprosy	0.00077	0.00676	CcSEcCtD
Arformoterol—Pharyngitis—Thalidomide—leprosy	0.000762	0.00669	CcSEcCtD
Arformoterol—Urinary tract disorder—Thalidomide—leprosy	0.000758	0.00666	CcSEcCtD
Arformoterol—Oedema peripheral—Thalidomide—leprosy	0.000756	0.00664	CcSEcCtD
Arformoterol—Urethral disorder—Thalidomide—leprosy	0.000753	0.00661	CcSEcCtD
Arformoterol—Visual impairment—Thalidomide—leprosy	0.00074	0.0065	CcSEcCtD
Arformoterol—Cardiac disorder—Thalidomide—leprosy	0.000713	0.00626	CcSEcCtD
Arformoterol—Immune system disorder—Thalidomide—leprosy	0.000694	0.00609	CcSEcCtD
Arformoterol—Mediastinal disorder—Thalidomide—leprosy	0.000692	0.00608	CcSEcCtD
Arformoterol—Arrhythmia—Thalidomide—leprosy	0.000686	0.00602	CcSEcCtD
Arformoterol—Vomiting—Dapsone—leprosy	0.000678	0.00595	CcSEcCtD
Arformoterol—Mental disorder—Thalidomide—leprosy	0.000673	0.00591	CcSEcCtD
Arformoterol—Malnutrition—Thalidomide—leprosy	0.000668	0.00587	CcSEcCtD
Arformoterol—Headache—Dapsone—leprosy	0.000668	0.00586	CcSEcCtD
Arformoterol—Tension—Thalidomide—leprosy	0.000656	0.00576	CcSEcCtD
Arformoterol—Dysgeusia—Thalidomide—leprosy	0.000655	0.00575	CcSEcCtD
Arformoterol—Nervousness—Thalidomide—leprosy	0.000649	0.0057	CcSEcCtD
Arformoterol—Back pain—Thalidomide—leprosy	0.000647	0.00568	CcSEcCtD
Arformoterol—Muscle spasms—Thalidomide—leprosy	0.000643	0.00564	CcSEcCtD
Arformoterol—Nausea—Dapsone—leprosy	0.000633	0.00556	CcSEcCtD
Arformoterol—Tremor—Thalidomide—leprosy	0.000626	0.0055	CcSEcCtD
Arformoterol—Ill-defined disorder—Thalidomide—leprosy	0.00062	0.00545	CcSEcCtD
Arformoterol—Agitation—Thalidomide—leprosy	0.000614	0.0054	CcSEcCtD
Arformoterol—Angioedema—Thalidomide—leprosy	0.000611	0.00536	CcSEcCtD
Arformoterol—Malaise—Thalidomide—leprosy	0.000603	0.00529	CcSEcCtD
Arformoterol—Palpitations—Thalidomide—leprosy	0.000591	0.00519	CcSEcCtD
Arformoterol—Cough—Thalidomide—leprosy	0.000583	0.00512	CcSEcCtD
Arformoterol—Hypertension—Thalidomide—leprosy	0.000577	0.00507	CcSEcCtD
Arformoterol—Myalgia—Thalidomide—leprosy	0.000569	0.005	CcSEcCtD
Arformoterol—Arthralgia—Thalidomide—leprosy	0.000569	0.005	CcSEcCtD
Arformoterol—Chest pain—Thalidomide—leprosy	0.000569	0.005	CcSEcCtD
Arformoterol—Anxiety—Thalidomide—leprosy	0.000567	0.00498	CcSEcCtD
Arformoterol—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.000565	0.00496	CcSEcCtD
Arformoterol—Discomfort—Thalidomide—leprosy	0.000562	0.00494	CcSEcCtD
Arformoterol—Dry mouth—Thalidomide—leprosy	0.000557	0.00489	CcSEcCtD
Arformoterol—Oedema—Thalidomide—leprosy	0.000546	0.00479	CcSEcCtD
Arformoterol—Infection—Thalidomide—leprosy	0.000542	0.00476	CcSEcCtD
Arformoterol—Nervous system disorder—Thalidomide—leprosy	0.000535	0.0047	CcSEcCtD
Arformoterol—Tachycardia—Thalidomide—leprosy	0.000532	0.00468	CcSEcCtD
Arformoterol—Skin disorder—Thalidomide—leprosy	0.00053	0.00465	CcSEcCtD
Arformoterol—Hypotension—Thalidomide—leprosy	0.00051	0.00448	CcSEcCtD
Arformoterol—Musculoskeletal discomfort—Thalidomide—leprosy	0.000497	0.00437	CcSEcCtD
Arformoterol—Insomnia—Thalidomide—leprosy	0.000493	0.00433	CcSEcCtD
Arformoterol—Dyspnoea—Thalidomide—leprosy	0.000486	0.00427	CcSEcCtD
Arformoterol—Somnolence—Thalidomide—leprosy	0.000485	0.00426	CcSEcCtD
Arformoterol—Dyspepsia—Thalidomide—leprosy	0.00048	0.00422	CcSEcCtD
Arformoterol—Gastrointestinal disorder—Thalidomide—leprosy	0.000471	0.00414	CcSEcCtD
Arformoterol—Fatigue—Thalidomide—leprosy	0.00047	0.00413	CcSEcCtD
Arformoterol—Pain—Thalidomide—leprosy	0.000466	0.0041	CcSEcCtD
Arformoterol—Constipation—Thalidomide—leprosy	0.000466	0.0041	CcSEcCtD
Arformoterol—Feeling abnormal—Thalidomide—leprosy	0.00045	0.00395	CcSEcCtD
Arformoterol—Gastrointestinal pain—Thalidomide—leprosy	0.000446	0.00392	CcSEcCtD
Arformoterol—Urticaria—Thalidomide—leprosy	0.000433	0.00381	CcSEcCtD
Arformoterol—Body temperature increased—Thalidomide—leprosy	0.000431	0.00379	CcSEcCtD
Arformoterol—Abdominal pain—Thalidomide—leprosy	0.000431	0.00379	CcSEcCtD
Arformoterol—Hypersensitivity—Thalidomide—leprosy	0.000402	0.00353	CcSEcCtD
Arformoterol—Asthenia—Thalidomide—leprosy	0.000391	0.00344	CcSEcCtD
Arformoterol—Pruritus—Thalidomide—leprosy	0.000386	0.00339	CcSEcCtD
Arformoterol—Diarrhoea—Thalidomide—leprosy	0.000373	0.00328	CcSEcCtD
Arformoterol—Dizziness—Thalidomide—leprosy	0.000361	0.00317	CcSEcCtD
Arformoterol—Vomiting—Thalidomide—leprosy	0.000347	0.00305	CcSEcCtD
Arformoterol—Rash—Thalidomide—leprosy	0.000344	0.00302	CcSEcCtD
Arformoterol—Dermatitis—Thalidomide—leprosy	0.000344	0.00302	CcSEcCtD
Arformoterol—Headache—Thalidomide—leprosy	0.000342	0.003	CcSEcCtD
Arformoterol—Nausea—Thalidomide—leprosy	0.000324	0.00285	CcSEcCtD
